In our group, we already described the expression of HLA-G in gastric tumors (6, Supplementary Material), and a closer look to the in vivo effect of the immunomodulatory properties of HLA-G in the tumor microenvironment should address the importance of this molecule in the evolution and possible therapies of this pathology. The gene discussed is HLA-G; the disease is gastric neoplasm.